Clinical Profile and Treatment Patterns in Individuals with Type 2 Diabetes and Chronic Kidney Disease Who Initiate a GLP-1 Receptor Agonist: A Multinational Cohort Study.
Saved in:
| Title: | Clinical Profile and Treatment Patterns in Individuals with Type 2 Diabetes and Chronic Kidney Disease Who Initiate a GLP-1 Receptor Agonist: A Multinational Cohort Study. |
|---|---|
| Authors: | Pladevall-Vila M; RTI Health Solutions, Barcelona, Spain.; The Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, MI, USA., Ziemiecki R; RTI Health Solutions, Research Triangle Park, NC, USA., Johannes CB; RTI Health Solutions, Waltham, MA, USA., Khan AM; RTI Health Solutions, Waltham, MA, USA., Mines D; The Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit, MI, USA., Ebert N; Institute of Public Health, Charité - Universitätsmedizin Berlin, Berlin, Germany., Kovesdy CP; Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA., Thomsen RW; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Baak BN; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., García-Sempere A; Health Services Research and Pharmacoepidemiology Unit, Fisabio, Spain., Kanegae H; Genki Plaza Medical Centre for Health Care, Tokyo, Japan., Coleman CI; University of Connecticut School of Pharmacy, Storrs, CT, USA.; Evidence-Based Practice Center, Hartford Hospital, Hartford, CT, USA., Walsh M; Division of Nephrology, Department of Medicine, McMaster University, Hamilton, ON, Canada., Andersen IT; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Bernal CR; Health Services Research and Pharmacoepidemiology Unit, Fisabio, Spain., Cabaniñas CR; Health Services Research and Pharmacoepidemiology Unit, Fisabio, Spain., Christiansen CF; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Farjat AE; Bayer AG, Leverkusen, Germany., Gay A; National Kidney Foundation Advocacy, Richmond, VA, USA., Gee P; National Kidney Foundation Advocacy, Richmond, VA, USA., Herings RMC; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Hurtado I; Health Services Research and Pharmacoepidemiology Unit, Fisabio, Spain., Kashihara N; Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Japan., Kristensen FPB; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark., Liu F; Bayer AG, Leverkusen, Germany., Okami S; Bayer AG, Leverkusen, Germany., Overbeek JA; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Beest FJAP; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands., Yamashita S; Bayer AG, Leverkusen, Germany., Yano Y; Department of General Medicine, Faculty of Medicine, Juntendo University, Tokyo, Japan., Layton JB; RTI Health Solutions, Research Triangle Park, NC, USA., Vizcaya D; Bayer AG, Leverkusen, Germany., Oberprieler NG; Bayer AG, Leverkusen, Germany. niki.oberprieler@bayer.com. |
| Source: | Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2025 May; Vol. 16 (5), pp. 931-954. Date of Electronic Publication: 2025 Mar 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Healthcare Country of Publication: United States NLM ID: 101539025 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1869-6953 (Print) Linking ISSN: 18696961 NLM ISO Abbreviation: Diabetes Ther Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1869-6953 |
|---|---|
| DOI: | 10.1007/s13300-025-01717-8 |
